Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Press Release
|
| ||||||
Patriot Scientific Reports Fiscal 2007 Net Income $23.7M or $0.06 Diluted EPS
CARLSBAD, Calif., Aug. 15 /PRNewswire-FirstCall/ -- Patriot Scientific Corporation (OTC Bulletin Board: PTSC- News) today filed its 10-K annual report for its fiscal year ending May 31, 2007. The company reported net income of $23.7 million, or $0.06 per diluted share, for the fiscal year 2007, as compared to net income of $28.7 million and $0.07 per diluted share for the previous fiscal year.
About Patriot Scientific Patriot Scientific is a leading intellectual property licensing company that develops, markets, and enables innovative technologies to address the demands in fast-growing markets such as wireless devices, smart cards, home appliances and gateways, set-top boxes, entertainment technology, automotive telematics, biomedical devices and industrial controllers. Headquartered in Carlsbad, Calif., information about the company can be found at http://www.ptsc.com. An investment profile on Patriot Scientific may be found at http://www.hawkassociates.com/ptscprofile.aspx. Copies of Patriot Scientific press releases, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com. About the Patent Portfolio The patent portfolio, marketed as the Moore Microprocessor Patent Portfolio, contains intellectual property that is jointly owned by the publicly held Patriot Scientific Corporation and the privately held TPL Group. The portfolio encompasses seven U.S. patents as well as their European and Japanese counterparts. Both TPL and Patriot assert that their jointly owned patents protect techniques used in designing microprocessors, microcontrollers, Digital Signal Processors (DSPs), embedded processors and System-on-Chip (SoC) implementations. The MMP Portfolio is exclusively managed by Alliacense, a TPL Group Enterprise. Moore Microprocessor Patent, MMP and Alliacense are trademarks of Technology Properties Limited (TPL). PTSC and Ignite are trademarks of Patriot Scientific Corporation. All other trademarks belong to their respective owners. CONTACTS: Patriot Media Relations John Radewagen VP CorpCom The Hoffman Agency 408-975-3005 (direct) 408-219-9199 (cell) jradewagen@hoffman.com http://www.hoffman.com Patriot Investor Relations Hawk Associates Frank Hawkins or Ken AuYeung (305) 451-1888 info@hawkassociates.com Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings. Source: Patriot Scientific Corporation_ |
New Message
Please
login
to post a reply